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Manganese-deficient rats exhibited seven-fold lower preproinsulin mRNA levels compared to control, as detected by dot 
blot hybridization of both total and poly(A)+ RNA using a preproinsulin cDNA probe. No differences in the size of 
the insulin mRNA were observed. Thus, decreased mRNA levels may be a major contributing factor to the decreased 
insulinogenesis observed in manganese-deficient ra s. 
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1. INTRODUCTION 
A fundamental problem in diabetes is the in- 
ability to utilize blood glucose efficiently. In type 
1 diabetics, the apparent defect is inadequate pan- 
creatic insulin secretion, resulting in low cir- 
culating plasma insulin levels that are inadequate 
for maintenance of glucose homeostasis. A role for 
manganese (Mn) in pancreatic insulin synthesis 
and secretion has been proposed [ 1,2]. Consistent 
with this idea, we have previously shown that 
manganese deficiency leads to impaired pandreatic 
insulin secretion [3]. Our studies suggested that the 
decreased insulin output from Mn-deficient pan- 
creata was due to decreased insulin biosynthesis as 
well as increased degradation [4]. 
Pancreatic insulin synthesis and secretion is 
regulated by a number of factors [5]. However, 
glucose appears to be a primary signal for these 
processes. Several studies suggest that glucose 
stimulates insulin synthesis at both the transcrip- 
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tional and translational evel [6-lo]. While glucose 
has been shown to induce the synthesis of 
preproinsulin mRNA, this process appears to be 
more important in the long-term regulation of in- 
sulinogenesis [6-8, lo]. Several recent studies sug- 
gest that insulin biosynthesis is acutely controlled 
at the translational evel by glucose [9,11]. Glucose 
appears to stimulate elongation rates, stimulate 
protein synthesis, and increase the transfer of in- 
itiated insulin mRNA molecules from the 
cytoplasm to microsomal membranes [9]. In addi- 
tion, glucose has also been shown to protect insulin 
mRNAs from degradation [12]. 
The purpose of the present study was to examine 
the cellular mechanisms by which Mn deficiency 
affects pancreatic insulinogenesis. With this in 
mind, we measured preproinsulin mRNA levels in 
Mn-deficient rats. We found that Mn-deficient rats 
had significantly lower preproinsuiin mRNA levels 
compared to controls. Characterization of the 
message by Northern analysis indicated no dif- 
ferences in the size of the insulin mRNAs from 
control or Mn-deficient rats. These studies provide 
insight into how Mn affects cellular processes that 
may ultimately be important in understanding the 
pathogenesis and potential treatments of diabetes. 
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2. MATERIALS AND METHODS 
2.1. Animals and diets 
Weanling female Sprague-Dawley rats (Charles River, Wil- 
mington, DE) were fed a purified diet containing either 45 peg 
Mn/g (Control) or 1 pug Mn/g (Mn-). At maturity (approx. 2 
months of age), rats were mated with stock-fed (Purina Rat 
Chow, Ralston Purina Co., St. Louis, MO) males. Animals 
were fed their respective diets throughout pregnancy and allow- 
ed to deliver their young. Offspring remained with their dams 
until weaning (30 days postpartum) and had free access to the 
maternal diet at all times during lactation [2]. Male offspring (3 
months of age) of both control (n = 6) and Mn- (n = 7) rats 
were used in these studies. Tissue manganese was analyzed by 
atomic absorption spectrophotometry toconfirm the deficiency 
131. 
2.2. Pancreatic RNA extraction 
Fresh pancreatic tissue was rapidly homogenized in 5 vols of 
4 M guanidinium isothiocyanate per gram of tissue. Total RNA 
was isolated using the hot phenol/chloroform extraction 
method of Maniatis et al. [12]. The final RNA pellet was rinsed 
with 70% ethanol and dissolved in sterile water for further 
analysis. The purity of the RNA was assessed by absorbance at 
260/280 nm. The integrity of the RNA isolated was assessed by 
an in vitro wheat germ translation system. The RNA was 
translated in the presence of [“Slmethionine, followed by SDS- 
PAGE autoradiography. The presence of high molecular mass 
35S-labeled proteins confirmed that the mRNAs isolated had 
not been degraded. 
2.3. Poly(A)+ RNA isolation 
Total RNA samples were heated to 65°C for 5 min in 20 mM 
Tris-HCl, 0.5 M NaCl, 1 mM EDTA, 0.1% SDS sample buffer 
(pH 7.4). Poly(A)+ RNA was isolated from these samples using 
oligo(dT)-cellulose chromatography, as described by Maniatis 
et al. [12]. 
2.4. Preproinsulin mRNA determination 
2.4.1. Dot blot hybridization 
RNA, extracted as above, was denatured by heating to 100°C 
for 5 min and the RNA bound to nitrocellulose paper by 
vacuum filtration. The nitrocellulose paper, baked for 2 h at 
8O”C, was prehybridized and hybridized as described by 
Thomas [14]. Rat preproinsulin gene I in PBR322 was nick- 
translated (Bethesda Research Labs) using [(r-“P]dCTP and 
subsequently purified by Sephadex G-50 chromatography. The 
specific activity of the probe averaged 3.4 x 10’ cpm/mg. Yeast 
tRNA was also blotted to monitor nonspecific binding of the 
probe. No binding of the labeled cDNA probe to yeast tRNA 
was observed. Increasing amounts of both total (20-1OOpg) 
and poly(A)+ (l-6,ug) RNA were hybridized to the labeled 
preproinsulin cDNA probe to determine the linear range of 
RNA hybridization to the probe. For visualization of the dots, 
autoradiography was performed at - 70°C for 18-40 h. In ad- 
dition, hybridization assays were quantitated by cutting out the 
32P-labeled ot blot and counting in a scintillation counter. 
Duplicate hybridization experiments were carried out on both 
total and poly(A)+ RNA using a B-actin cDNA probe. 
Hybridization of the labeled actin cDNA probe revealed no dif- 
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ferences in mRNA content between Mn-deficient and control 
animals, ruling out a nonspecific effect of Mn deficiency on 
mRNA content or variable recovery of poly(A)+ RNA during 
oligo(dt) chromatography. 
2.4.2. Northern analysis 
The poly(A)+ RNA precipitates were denatured with 2.2 M 
formaldehyde and 50% (v/v) formamide in 40 mM Mops, 
10 mM sodium acetate, 1 mM EDTA at 55°C for 15 min. The 
samples were electrophoresed on 1.5% agarose gels before 
transfer to nitrocellulose [131. Hybridization was carried out as 
described previously [14]. Visualization was carried out by 
autoradiography as described previously. Northern blot 
analyses of islet RNA prepared by the above method revealed 
no degradation of insulin mRNA. 
2.4.3. Statistical analysis 
Data were analyzed using a one-way analysis of variance 
(ANOVA). Group comparisons were made using the least 
significant difference method when a significant F was reached. 
3. RESULTS 
Pancreatic manganese content was significantly 
@ < 0.05) lower in manganese-deficient animals 
(0.67 f 0.10 pg/g pancreas) compared to controls 
(2.40 + O.l6gg/g pancreas). No significant dif- 
ferences in body weight or pancreatic weight were 
observed. The 260/280 absorbance ratio of the 
pancreatic RNA isolated averaged 1.94. In vitro 
translation of the RNA yielded both high and low 
molecular mass bands on SDS-PAGE (not shown), 
indicating the mRNAs isolated had not been 
significantly degraded. 
3.1. Preproinsulin mRNA levels 
Hybridization of 32P-labeled probe to increasing 
amounts of total RNA (20-1OOpg) and poly(A)+ 
RNA (l-6 pg) showed a linear increase in the 
amount of labeled probe hybridized (not shown). 
Hybridization of labeled probe to total RNA 
(100 ,ug) demonstrates lower preproinsulin mRNA 
levels in Mndeficient rats (n = 7) compared to 
controls (n = 6). A typical experiment is shown in 
fig.1. Similar results were observed with poly(A)+ 
RNA extracts (fig.lB). Fig.2 summarizes the 
results of 12 hybridizations of poly(A)+ RNA from 
control and Mn-deficient rats. Preproinsulin 
mRNA levels were 9-fold lower in Mn-deficient 
animals compared to those of controls. 
3.2. Northern analysis 
Northern blot hybridization (fig.3) of poly(A)+ 
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Fig.1. Effect of manganese deficiency on pancreatic insulin 
mRNA levels. Pancreatic RNA from three Mn-deficient and 
two control rats was phenol extracted and ethanol precipitated. 
The content of insulin mRNA was quantitated by dot 
hybridization as described in section 2. (A) Dot hybridization of 
insulin mRNA from total RNA extracts of Mn-deficient (l-3) 
and control (4 and 5) rats. (B) Dot hybridization of insulin RNA 
from poly(A)+ RNA extracts of Mn-deficient (l-3) and control 
(4-6) rats. 
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Fig.2. Insulin mRNA levels in poly(A)+ RNA extracts from 
control and Mn-deficient rats. Poly(A)+ RNA extracts were 
prepared by oligo(dt)-cellulose chromatography as described in 
section 2. The vertical bar represents mean + SE of 6 control 
rats and 7 Mn-deficient rats. 
Fig.3. Northern analysis of insulin mRNA from control and 
Mn-deficient rats. Poly(A)+ RNA extracts were denatured with 
2.2 M formaldehyde and 50% (v/v) formamide, 10 mM 
sodium acetate, 1 mM EDTA at 55°C for 15 min. The samples 
were subjected to electrophoresis on 1.5% agarose gels and then 
transferred to nitrocellulose. Hybridization was carried out as 
described in section 2. Lanes l-3 are from Mn-deficient rats 
and lanes 4-6 are from control rats. The relative mobilities of 
16-28 S standards are shown on the right. PImRNA represents 
the preproinsulin mRNA bands. 
RNA demonstrates that both control and Mn- 
deficient rats had preproinsulin mRNAs of the 
same size. In addition, the same pattern of de- 
creased amounts of preproinsulin mRNA in Mn- 
deficient rats was observed. 
4. DISCUSSION 
We have previously demonstrated that insulin 
biosynthesis in response to a maximally 
stimulating glucose concentration (300 mg/dl) is 
decreased 9-fold in Mn-deficient rats compared to 
controls [I]. This decrease in insulinogenesis could 
be due to several factors, including decreased in- 
sulin gene transcription, altered insulin mRNA 
processing, or impaired conversion of proinsulin 
to insulin. The first two possibilities could lead to 
decreased mRNA levels as well as alterations in the 
size of the insulin mRNA synthesized in Mn- 
deficient rats. In the present study, we have begun 
57 
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to explore at what level low intracellular concen- 
trations of Mn affect insulinogenesis. The data 
demonstrate that insulin mRNA levels are de- 
creased 9-fold in Mn-deficient rats compared to 
controls. The fold reduction in insulin mRNA 
levels in this study is strikingly similar to the 
decrease in insulinogenesis previously observed in 
Mn-deficient rats. Thus, the data strongly suggest 
that the decreased amount of insulin mRNA is a 
major factor contributing to the decreased glucose- 
induced insulin synthesis seen in islets from Mn- 
deficient rats. This decreased insulin mRNA prob- 
ably represents a long-term adaptation of these 
animals to the deficiency. The specific mechanisms 
by which low intracellular Mn may affect insulin 
mRNA content remains to be elucidated. Several 
likely possibilities include impaired insulin gene 
transcription, altered insulin mRNA processing or 
translatability, and altered cytosolic stability of ex- 
isting mRNAs. 
We have begun to address these possibilities by 
characterizing the insulin message using Northern 
analysis. In these studies mRNAs from control and 
Mn-deficient animals were similar with respect to 
size. This would suggest that mRNA processing 
was not affected by Mn deficiency. However, ef- 
fects of Mn deficiency on mRNA processing can- 
not be ruled out since most defective transcripts 
never leave the nucleus. Thus, examining trans- 
cription rates and message turnover in nuclei will 
be important. We have also examined the ability of 
glucose to induce new insulin mRNA synthesis by 
injecting fasted rats with glucose over a 12 h 
period. Preliminary data from these studies sug- 
gest that glucose was equally able to induce new 
mRNA synthesis as evidenced by similar mRNA 
content in glucose-injected deficient and control 
animals. Thus, insulin gene transcription may not 
be affected by Mn deficiency. However, effects of 
manganese on gene transcription cannot as yet be 
ruled out as these studies were done in whole 
animals, where blood glucose concentrations are 
tightly regulated (5-9 mM following glucose injec- 
tions). Maximal effects of glucose on insulin 
mRNA synthesis require 16-20 mM glucose 
[9- 111. In addition, fasting followed by glucose in- 
jection will affect many physiological events in the 
whole animals, which may impinge on pancreatic 
insulin homeostasis, masking specific effects of 
glucose on insulin mRNA levels. Thus definitive 
studies will require the use of isolated islets. 
Studies designed to address the biochemical 
mechanisms underlying manganese’s effect on in- 
sulin mRNA content are currently being done in 
our laboratory. 
In conclusion, these studies provide insight into 
how Mn affects cellular processes that may 
ultimately be important in understanding the 
pathogenesis and potential treatments of diabetes. 
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